Global Metabolomics Market Tends to Develop at a CAGR of 11.3% during Forecast Period 2016-2024

According to Goldstein Research, the global metabolomics market is projected to nurture at a CAGR of 11.3% during the forecast period 2016-2024 to reach USD 2.1 billion by 2024. One trend is that the metabolomics may provide a path for achieving more comprehensive and personalized trauma care, which can function as a rapid, serial, and precise tool to characterize metabolism in trauma patients as they recover from injury. Further, improving the route from early drug discovery through clinical development as drug discovery is a risky and complex process with just 12% of drugs entering the clinical trials ever to make it to the patients is expected to propel the market growth at a significant pace. However, to provide actionable information to the physician from all the big data generated by multi-omics is posing a major challenge for the global metabolomics market growth. Global Metabolomics market segmentation has been done on the basis of product & services, indication, application, and geography.

Based on applications, biomarker & drug discovery segment dominated the market in 2016 with 30.1% market share owing to its advancements in metabolomics technologies and its implications to diagnose disease, understand disease mechanisms, identify novel drug targets, customize drug treatments and monitor therapeutic outcomes. Additionally, metabolomics market is largely dominated by North America with a market share of 37.5% in 2016 owing to growing research and development activities in functional genomics, nutrigenomics and toxicology and the presence of a large number of leading metabolomics manufacturers.

Market Segmentation

On the basis of our in-depth analysis, Global Metabolomics Market can be segmented and sub-segmented as follows:

By Product & Service

• High-Performance Liquid Chromatography
• Gas Chromatography
• Ultra-Performance Liquid Chromatography
• Capillary Electrophoresis
• Mass Spectrometry
• Nuclear Magnetic Resonance Spectroscopy
• Surface-Based Mass Analysis
• Bioinformatics Tools & Databases
• Bioinformatics Services

By Indication

• Cancer
• Cardiovascular Disorder
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Indications

By Application

• Personalized Medicine
• Genome Mining
• Strain Optimization
• Spot Adulteration
• Agriculture Biotechnology
• Biotic/Abiotic Stress
• Biomarker & Drug Discovery

Based on Region

• North America (United States, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
• Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Asia Pacific metabolomics Market(China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-metabolomics-market-analysis

“Metabolomics Market Outlook 2024” contains a detailed overview of the global metabolomics market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by product & services, indication, and application.

Further, for the in-depth analysis, Global Metabolomics Market Report technology and end-user encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

This industry analysis report also includes competitive outlook of some of the major players profiling of companies such as Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Danaher Corporation, Shimadzu Corporation, Metabolon Inc., LECO Corporation, Biocrates Life Sciences AG, Human Metabolome Technologies, Inc., Waters Corporation, Phenomenome Discoveries Inc., Metabolon, Agilent Technologies, Bruker Corporation, Human Metabolome Technology, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services, and industries catered, financial analysis of the company and recent developments.

Browse Full Report: https://www.goldsteinresearch.com/report/global-metabolomics-market-analysis

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

99 Wall Street, Suite No-
527, New York, NY 10005

This release was published on openPR.